How Much Should You Invest in Pursuing a New Business Idea?

Once you've decided a new product or business idea is worth pursuing, the next question is how much to put behind it. This is where a lot of good ideas get funded to death or starved before they had a chance, because the amount usually gets set the wrong way: as a number decided up front, before the information that should determine it exists.

That number tends to come from one of two places. Sometimes it's a budget handed down at the start and then spent whether or not the early results justify continuing. Sometimes it's sized to the prize, a heavy commitment made because the upside looks enormous. The trouble is the same either way. The figure gets locked in without reference to the one thing that should govern early-stage spending, which is uncertainty, and at the beginning you know almost nothing: not enough to deserve a big commitment, and not enough to rule the idea out either.

Invest in increments, not in one decision

The better frame is to stop thinking of the investment as a single number and start thinking of it as a series of increments, each one buying down the risk that matters most at that moment. You are not funding the whole idea. You are funding the next step, and the next step's job is to reduce the biggest remaining uncertainty as cheaply as possible.

That reframes what your money is buying. Early on, you are not building the business. You are buying evidence, information that tells you whether the idea's riskiest assumptions hold. The right size for the next increment is roughly the cost of getting a trustworthy answer to the most important open question, and no more than that. In practice the scale of that increment is driven by what the experiment to test your most critical assumption actually costs, weighed against the probability-weighted value it could unlock: a test that could confirm a large payoff, and looks likely to, earns a bigger increment than one gating a marginal one. Spend enough to learn something real; don't spend so much that you've committed to the answer before you have it.

What you are really buying is an option

There's a concept from finance that captures this exactly, and it's worth borrowing. Early-stage spending buys an option: the right, but not the obligation, to keep going. When you fund a small experiment, you aren't committing to the venture. You're purchasing the ability to decide later, with better information, whether to commit at all.

That reframes "how much" around two things. An option is worth most when uncertainty is high and the cost of learning is low, which is precisely the early stage. So the discipline is to keep the early increments small, aim them at the assumptions most likely to be fatal, and preserve your ability to walk away cheaply. The goal isn't to minimize spending in the abstract. It's to buy the most learning, and the most future optionality, per dollar committed, while the cost of being wrong is still small. Sometimes what that option buys you is the information to change direction rather than continue, which is its own kind of return, a point we develop in what-if modeling and the value of the pivot.

Let the evidence raise the bar

As evidence accumulates and the biggest risks retire, two things move together: your confidence goes up, and the size of the commitment you're willing to make goes up with it. Small money on thin evidence early; larger money only once the dangerous unknowns have been tested and survived. This staged escalation is what keeps you from betting big on a hunch and from under-funding something that has actually earned more.

The trigger for the next increment should be evidence, not the calendar. Releasing money because it's the start of a new budget year, or holding it because the annual cycle hasn't come around, breaks the link between investment and what you've learned. The right question at each step is not "is it time to fund the next phase?" but "has this earned the next phase?" Fund against readiness, and the amount takes care of itself, because each increment is sized to the question in front of you.

The rule of thumb

So the answer to "how much should I invest?" is not a percentage or a fixed figure. It's this: invest enough to meaningfully reduce the next critical uncertainty, and no more, then let the result decide whether the next, larger increment is warranted. Size each step to what it buys, keep the option to stop cheap, and let evidence rather than ambition or the budget cycle set the pace.

That approach connects directly to the questions on either side of it: whether the idea is worth pursuing at all, and when to stop if the evidence turns against it. Managing that staged, evidence-driven investment across a whole portfolio of ideas, rather than one at a time, is where it becomes a real discipline, and it's what our consulting work and Growth Forge® Software are built to support.

BRI Associates helps companies grow by drawing on decades of practitioner experience in corporate innovation and new business development — practitioners, not pundits or academics — through direct consulting, training workshops, and Growth Forge® Software, built for the unique requirements of corporate innovation and growth organizations.